Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
Status:
Withdrawn
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study aims to compare the safety, tolerability, and efficacy of voriconazole and
anidulafungin in combination versus voriconazole alone in pediatric subjects aged 2 to 17
years with invasive aspergillosis.